Trade JnJ ^JNJ

Addison Advisors LLC Sells 7,675 Shares of Johnson & Johnson $JNJ

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

This Popular Healthcare ETF Is Diluting Your Dividend Income

These 3 Dividend Stocks Have Survived Every Recession Since 1970. Retirees Trust Them for a Reason.

Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch.

Meeder Asset Management Inc. Lowers Stock Holdings in Johnson & Johnson $JNJ

Main Street Financial Solutions LLC Takes Position in Johnson & Johnson $JNJ - Stock Observer

Promising Pharmaceutical Stocks Worth Watching - August 30th - Daily Political

MidFirst Bank Decreases Stock Position in Johnson & Johnson $JNJ

Commerzbank Aktiengesellschaft FI Raises Stock Position in Johnson & Johnson $JNJ

Beverly Hills Private Wealth LLC Sells 8,797 Shares of Johnson & Johnson $JNJ

BlackRock Inc. Has $53.87 Billion Position in Johnson & Johnson $JNJ

MidFirst Bank Decreases Stock Holdings in Johnson & Johnson $JNJ - Stock Observer

Johnson & Johnson $JNJ Stock Position Cut by Persistent Asset Partners Ltd - Stock Observer

Johnson & Johnson Stock: Is JNJ Outperforming the Consumer Staples Sector?

Pharmaceutical Stocks To Add to Your Watchlist - August 29th - Daily Political

Trivium Point Advisory LLC Buys 2,217 Shares of Johnson & Johnson $JNJ

Global Retirement Partners LLC Makes New $17.05 Million Investment in Johnson & Johnson $JNJ

Simplicity Wealth LLC Boosts Stock Holdings in Johnson & Johnson $JNJ

Flputnam Investment Management Co. Boosts Holdings in Johnson & Johnson $JNJ - Zolmax

Johnson & Johnson (JNJ) Stock Looks Reasonable On Its 82% Three Year Run

AMG National Trust Bank Reduces Stake in Johnson & Johnson $JNJ

Johnson & Johnson (JNJ) Taps Sail Biomedicines in Bid for CAR-T Edge Over Bristol Myers Squibb

Forget Nvidia. Johnson & Johnson and 2 Other AI Stocks Are Beating the Market by 29 Points.

Johnson & Johnson (NYSE:JNJ) Has A Better Balance Sheet Than The Government, Said Jim Cramer

J&J's China Pill Win Challenges Its Own Injection Franchise

Best Healthcare Stocks To Follow Now - August 28th - Daily Political

Kelleher Financial Advisors Has $3.19 Million Stake in Johnson & Johnson $JNJ - Markets Daily

Kelleher Financial Advisors Buys 2,254 Shares of Johnson & Johnson $JNJ - Zolmax

Private Advisory Group LLC Acquires 41,632 Shares of Johnson & Johnson $JNJ

Russell Investments Group Ltd. Cuts Stock Holdings in Johnson & Johnson $JNJ

SCS Capital Management LLC Has $26.73 Million Stake in Johnson & Johnson $JNJ

Private Advisory Group LLC Purchases 41,632 Shares of Johnson & Johnson $JNJ - Stock Observer

Johnson & Johnson's Psoriasis Pill Approved in China: A Game Changer in Skin Treatment, ETPharma

CORDA Investment Management LLC. Sells 3,626 Shares of Johnson & Johnson $JNJ - Daily Political

Johnson & Johnson (JNJ)'s Imaavy Expands Into Rare Blood Disorder: What Investors Should Know

New FDA Approval Gives Bristol-Myers Squibb (BMY) Another Potential Oncology Growth Catalyst

Johnson & Johnson (NYSE:JNJ) Stock Price Down 1.4% - Here's What Happened

I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now

Top Pharmaceutical Stocks To Research - August 27th - Zolmax

Top Healthcare Stocks To Watch Now - August 27th - Stock Observer

J&J's latest Impella recall tied to 3 deaths, 37 injuries

Mitsubishi UFJ Trust & Banking Corp Has $427.78 Million Stock Position in Johnson & Johnson $JNJ - Markets Daily

Johnson & Johnson $JNJ Shares Purchased by Mitsubishi UFJ Trust & Banking Corp

Mosaic Family Wealth Partners LLC Grows Stake in Johnson & Johnson $JNJ

Kinsale Capital Group Inc. Raises Stake in Johnson & Johnson $JNJ

Johnson & Johnson Just Got a Big FDA Win

Meridian Wealth Management LLC Has $13.60 Million Stake in Johnson & Johnson $JNJ - Stock Observer

Ageing, Innovation and AI: 10 Healthcare Stocks Positioned to Benefit | Financial Horse

CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial

Top Analyst Reports for JPMorgan, Johnson & Johnson & Mastercard

How Much Upside Is Left in JNJ Stock?

Top Healthcare Stocks To Keep An Eye On - August 26th - Markets Daily

Dividends vs. an Annuity: Which Turns $840,000 Into More Monthly Income for Life?

Atrial Fibrillation Treatment Devices Market Trends and Forecast, 2035 | Includes Profiles of Abbott, AtriCure, Boston Scientific, Johnson & Johnson, and Medtronic

HighTower Advisors LLC Sells 591,434 Shares of Johnson & Johnson $JNJ - Markets Daily

Janney Montgomery Scott LLC Reduces Stock Holdings in Johnson & Johnson $JNJ

Parr Mcknight Wealth Management Group LLC Purchases 5,142 Shares of Johnson & Johnson $JNJ - Stock Observer

GWN Securities Inc. Trims Stock Position in Johnson & Johnson $JNJ - Daily Political

Fifth Third Bancorp Cuts Stake in Johnson & Johnson $JNJ - Daily Political

Johnson & Johnson (JNJ) Stock: Surge as FDA Approval and European Cancer Treatment Expansion Drive Market Attention

Johnson & Johnson Is Near a Record High. Is There Still Room to Run?

"Give Me Anything But Tech": Jim Cramer's Bold Call on the Market's Next Big Rotation

Promising Pharmaceutical Stocks To Follow Now - August 25th - Daily Political

Strategic Wealth Investment Group LLC Reduces Holdings in Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Shares Acquired by Principal Financial Group Inc.

GraniteShares Advisors LLC Makes New Investment in Johnson & Johnson $JNJ

Golden Reserve Retirement LLC Has $1.72 Million Position in Johnson & Johnson $JNJ

FDA Approves J&J's IMAAVY For Warm Autoimmune Hemolytic Anemia

Strategic Wealth Investment Group LLC Sells 10,326 Shares of Johnson & Johnson $JNJ - Daily Political

Does Louisiana's US$10 Million Talc Verdict Shift the Legal Risk Bull Case For Johnson & Johnson (JNJ)?

FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patients | Morningstar

Q2 Earnings Season Winds Down: 3 Companies That Broke Records

J&J's Strong Pipeline Momentum Offers Multiple Growth Catalysts Ahead

Johnson & Johnson's multiple myeloma treatment secures EC approval

TD Asset Management Inc Grows Stock Holdings in Johnson & Johnson $JNJ

Willis Investment Counsel Raises Stock Holdings in Johnson & Johnson $JNJ - Stock Observer

Pfizer vs. Johnson & Johnson: Which Pharma Giant Is Better Prepared for Its Patent Cliff?

Towards precision psychiatry: initial foundations and future directions

Is Johnson & Johnson's $5.5 Billion Talc Settlement a Buy Signal, or Is the Legal Risk Far From Over?

Johnson & Johnson vs. Thermo Fisher: Which Healthcare Growth Story Is More Durable?

Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson?

This Company Has Raised Its Dividend for 72 Straight Years. Almost Nobody Talks About It.

How to Build $6,600 a Month in Dividend Income From Three Income Buckets

Johnson & Johnson (JNJ) Wins EU Approval For TECVAYLI Combo In Multiple Myeloma

2 Dividend Stocks to Buy and Never Sell

Johnson & Johnson $JNJ Stock Position Boosted by Osprey Private Wealth LLC

Johnson & Johnson $JNJ is Pinnacle Associates Ltd.'s Largest Position

BIP Wealth LLC Has $3.98 Million Position in Johnson & Johnson $JNJ

 Week Ahead: Inflation Data from U.S., Canada, and U.K. Take Centre Stage

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Week Ahead: BoC and ECB Interest Rate Decisions in Focus This Week

Week ahead: ECB set to cut as Wall Street earnings season gathers pace

Week ahead: US earnings season kicks off, ECB hold expected

Europe Tries to Ride on US Coat-tails

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk